These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group. Worldwide Atosiban versus Beta-agonists Study Group. BJOG; 2001 Feb; 108(2):133-42. PubMed ID: 11236112 [Abstract] [Full Text] [Related]
10. The development and introduction of anti-oxytocic tocolytics. Lamont RF. BJOG; 2003 Apr; 110 Suppl 20():108-12. PubMed ID: 12763125 [Abstract] [Full Text] [Related]
11. Emerging issues over the choice of nifedipine, beta-agonists and atosiban for tocolysis in spontaneous preterm labour--a proposed systematic review by the International Preterm Labour Council. Beattie RB, Helmer H, Khan KS, Lamont RF, McNamara H, Svare J, Tsatsaris V, van Geijn HP, Steering Group, International Preterm Labour Council. J Obstet Gynaecol; 2004 Apr; 24(3):213-5. PubMed ID: 15203610 [No Abstract] [Full Text] [Related]
17. The use of atosiban and ritodrine in external cephalic version. Stergiotou I, Talbot F, Yoong W. Acta Obstet Gynecol Scand; 2007 Dec; 86(8):927-9. PubMed ID: 17653876 [Abstract] [Full Text] [Related]
18. [Which tocolytic drugs in case of preterm labor?]. Carbonne B, Tsatsaris V. J Gynecol Obstet Biol Reprod (Paris); 2002 Nov; 31(7 Suppl):5S96-104. PubMed ID: 12454631 [Abstract] [Full Text] [Related]